New immunotherapy method targets tumor tissue only
Immunotherapy drugs are promising new weapons in the fight against cancer, but they are so strong that they can be […]
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and […] Brain metastases are the most common type of brain tumors, affecting nearly 200,000 people in the United States each year. […] NEW YORK (Reuters Health) – Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction […] A dysfunctional immune system significantly contributes to the development of cancer. Several therapeutic strategies to activate the immune system to […] Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with immunotherapy, a new study suggests. Researchers believe […] Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut microbiome can transform […] Britain has been home to many pioneers of immunology, ranging from cellular biologists to virologists and biochemists. This article aims […] Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in […] THURSDAY, Nov. 19, 2020 — An algorithm that combines deep learning on histology slides and patient clinical data may predict […]immunotherapy
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model
Immunotherapy for brain metastases: Where are we now?
Pembrolizumab May Be Preferable to Chemo in Certain Patients
Study shows how melanoma cells evade detection and destruction by immune cells
Radiotherapy-resistant cancers could be rendered susceptible through immunotherapy treatment
Fecal transplant turns cancer immunotherapy non-responders into responders
Immunology: A Very British History
Scientists unlock promising key to preventing cancer relapse after immunotherapy
AI Model May Predict Immunotherapy Response in Melanoma